文献速递神经康复儿童康复

6Hz启动低频rTMS联合改良CIMT改善单侧脑瘫患儿上肢功能

Brain Stimulation and Constraint Induced Movement Therapy in Children With Unilateral Cerebral Palsy: A Randomized Controlled Trial.
PubMed 文献 · Neurorehabil Neural Repair · 2023-05-11

这项随机对照试验纳入46例5至18岁单侧脑瘫患儿,比较改良约束诱导运动疗法(mCIMT)联合真实或假6Hz启动低频重复经颅磁刺激(rTMS)的效果。4周时干预组上肢技能质量量表(QUEST)总分改善显著优于对照组,且12周时仍维持,未见严重不良事件。

要点

  • 6Hz启动低频rTMS联合mCIMT可安全用于5至18岁单侧脑瘫患儿。
  • 联合方案在4周时QUEST总分改善优于单用mCIMT,12周仍维持。
  • 负重与保护性伸展域评分改善更明显,12周时脑瘫生活质量量表(CP-QOL)改善。

核心结论

  • 6Hz启动低频rTMS联合mCIMT安全、可行,且改善单侧脑瘫患儿上肢功能优于单用mCIMT。

研究设计与样本

  • 随机对照试验,5至18岁单侧脑瘫患儿每臂23例,随机接受10次mCIMT联合真实或假rTMS,隔日进行、共4周。

主要发现

  • 4周时干预组QUEST总分平均变化11.66±6.97,对照组6.56±4.3,d=5.1,95%CI 1.7-8.5,P=.004。
  • 干预组「负重」与「保护性伸展」域评分改善显著更高,12周时改善仍维持(P=.028)。
  • 12周时CP-QOL评分改善,未见严重不良事件,46例中仅1例未完成试验。

关键数值与推荐

  • 主要结局为QUEST总分平均变化差异;4周时组间差异d=5.1,95%CI 1.7-8.5,P=.004。
  • 12周时改善维持的P=.028;试验注册号NCT03792789。

临床怎么用

  • 对5至18岁单侧脑瘫患儿,可考虑6Hz启动低频rTMS联合mCIMT作为改善上肢功能的康复方案,需关注安全性与可行性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is a crucial need to devise optimum rehabilitation programs for children with cerebral palsy (CP). OBJECTIVE: This study aimed to assess the feasibility, safety, and efficacy of combining 6-Hz primed, low-frequency, repetitive transcranial magnetic stimulation (rTMS) with modified constraint-induced movement therapy (mCIMT) in improving upper limb function in children with unilateral CP. METHODS: Children aged 5 to 18 years with unilateral CP were randomized (23 in each arm) to receive 10 sessions of mCIMT with real rTMS (intervention arm) or mCIMT with sham rTMS (control arm), on alternate weekdays over 4 weeks. The primary outcome was the difference in mean change in Quality of Upper Extremity Skills Test (QUEST) scores. Secondary outcomes were changes in QUEST domain scores, speed and strength measures, CP quality of life (CP-QOL) scale scores, and safety of rTMS. RESULTS: All 46 children completed the trial except one. At 4 weeks, the mean change in total QUEST scores was significantly higher in the intervention arm as compared to the control arm (11.66 ± 6.97 vs 6.56 ± 4.3, d = 5.1, 95% CI 1.7-8.5, P = .004). Change in "weight bearing" and "protective extension" domain score was significantly higher for children in the intervention arm. These improvements were sustained at 12 weeks (P = .028). CP-QOL scores improved at 12 weeks. No serious adverse events were seen. CONCLUSION: A 6-Hz primed rTMS combined with mCIMT is safe, feasible, and superior to mCIMT alone in improving the upper limb function of children with unilateral CP. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03792789.

来源:Neurorehabil Neural Repair,查看原文。版权归原作者所有。

引用

  1. Gupta J, Gulati S, Singh UP, et al. Brain Stimulation and Constraint Induced Movement Therapy in Children With Unilateral Cerebral Palsy: A Randomized Controlled Trial. Neurorehabil Neural Repair. 2023. PMID: 37170480. doi:10.1177/15459683231174222

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。